Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results

Psychopharmacology

Volumn 142, Issue 2, 1999, Pages 139-143

  Hutchison, Kent E ^a   Monti, Peter M ^b,c   Rohsenow, Damaris J ^b,c   Swift, Robert M ^b,c   Colby, Suzanne M ^b   Gnys, Maryann ^c   Niaura, Raymond S ^d   Sirota, Alan D ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b BROWN UNIVERSITY   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Craving; Naltrexone; Nicotine replacement patch Smoking cue; Urge

Indexed keywords

NALTREXONE; NICOTINE; OPIATE ANTAGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADULT; ANALYSIS OF VARIANCE; CUES; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NICOTINE; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032932672     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050872     Document Type: Article

References (34)

1. Abrams DB, Monti PM, Carey KB, Pinto RP (1988) Reactivity to smoking cues and relapse: two studies of discriminant validity. Behav Res Ther 26:225-233
2. Benjamin D, Grant ER, Pohorecky LA (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-140
3. Berg BJ, Pettinati HM, Volpicelli JR (1996) A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Safety 15:274-282
4. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, New Jersey
5. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR (1995) High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA 274:1353-1358
6. Drobes D, Tiffany S (1997) Induction of smoking urge through imaginal and in vivo procedures: Psychological and self-report manifestations. J Abnorm Psychol 106:15-25
7. Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159-181
8. Gorelick DA, Rose J, Jarvik ME (1989) Effect of naloxone on cigarette smoking. J Subst Abuse 1:153-159
9. Houtsmuller EJ, Clemmey PA, Sigler LA, Stitzer ML (1997) Effects of naltrexone on smoking and abstinence. In: Harris LS (ed) Problems of drug dependence 1996. proceedings of the 58th Annual Scientific Conference. NIDA Research Monograph 174, USDHHS, Washington, D.C.
10. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294
11. Hurt RD, Dale LC, Offord KP, Croghan IT (1995) Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction 90:1541-1546
12. Jorenby DE, Hatsukami DK, Smith SS, Fiore MC, Allen S, Jensen J, Baker TB (1996) Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology 128:130-138
13. Karras A, Kane J (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541-1545
14. Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, Behm FM, Rose JE (1994) Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacology 14:41-49
15. Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112:339-342
16. Malin DH, Lake JR, Payne MC, Short PE, Carter VA, Cunningham JS, Wilson OB (1996) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacol Biochem Behav 53:81-85
17. Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89:261-264
18. Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Abrams DA, Pedraza M (1988) The relevance of cue reactivity to understanding alcohol and smoking relapse. Abnorm Psychol 97: 33-152
19. Niaura RS, Abrams DB, Monti PM, Pedraza M (1989) Reactivity to high risk situations and smoking cessation outcome. J Subst Abuse 1:393-406
20. Niaura RS, Abrams DB, Monti PM, Pedraza M, Rohsenow DJ (1992) Smoker's reactions to interpersonal stress and environmental smoking cues. Addict Behav 17:557-566
21. Niaura RS, Shadel WG, Abrams DB, Monti PM, Rohsenow DJ, Sirota A (1998) Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict Behav (in press)
22. O'Malley SS, Jaffe AJ, Chang G, Shottenfield RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence; a controlled study. Arch Gen Psychiatry 49:881-887
23. O'Malley SS, Krishnana-Sarin S, Meandzija B (1997) Naltrexone treatment of nicotine dependence: a preliminary study. Poster presented to the 3rd annual scientific conference of the Society for Research on Nicotine and Tobacco, June, Nashville, Tenn.
24. Rose JE (1996) Nicotine addiction and treatment. Annu Rev Med 47:493-507
25. Russell MAH (1990) Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford University Press, Oxford
26. Sayette MA, Hufford MR (1994) Effects of cue exposure and deprivation on cognitive resources in smokers. J Abnorm Psychol 103:812-818
27. Shiffman S (1982) Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 50:71-86
28. Shiffman S (1993) Smoking cessation treatment: any progress? J Consult Clin Psychol 61:718-722
29. Sutherland G, Stapleton JA, Russell MAH, Feyerband G (1995) Naltrexone, smoking behavior and cigarette withdrawal. Psychopharmacology 120:418-425
30. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467
31. United States Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction: a report of the surgeon general. US Government Printing Office, Washington, D.C.
32. United States Department of Health and Human Services (1990) The health benefits of smoking cessation: a report of the surgeon general. DHHS Publication No. (CDC) 90-8416. Public Health Service, Washington, D.C.
33. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880
34. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Person Soc Psychol 54:1063-1070